Lunsford L, McKeever U, Eckstein V, Hedley M L
Zycos, Inc., Cambridge, MA 02138, USA.
J Drug Target. 2000;8(1):39-50. doi: 10.3109/10611860009009208.
Information regarding the distribution and persistence of DNA encapsulated in poly-(lactide co-glycolide) microspheres was collected to provide additional information regarding the safety of DNA vaccines and to support the clinical testing of this new delivery system for DNA. Plasmid DNA was encapsulated in poly(lactide co-glycolide) microspheres and the distribution and persistence of plasmid in murine tissues resulting from parenteral administration were examined by a sensitive PCR assay. Encapsulated DNA delivered by intramuscular or subcutaneous injection can be detected for 100 days post-injection and is distributed primarily at the site of injection and the lymphoid organs. Intravenous administration results in more widespread dissemination with long term persistence limited to the lymphoid organs and those of the reticuloendothelial system. Specific cellular uptake of DNA by professional antigen presenting cells (APCs) following injection suggests the utility of microspheres as DNA delivery agents. Distribution and persistence studies support the safety of encapsulated DNA and the specific cellular uptake of DNA by professional APCs following injection suggests the utility of microspheres as DNA delivery agents.
收集了有关包裹在聚(丙交酯-乙交酯)微球中的DNA的分布和持久性的信息,以提供有关DNA疫苗安全性的更多信息,并支持对这种新型DNA递送系统进行临床试验。将质粒DNA包裹在聚(丙交酯-乙交酯)微球中,并通过灵敏的PCR检测法检查经肠胃外给药后质粒在小鼠组织中的分布和持久性。通过肌肉注射或皮下注射递送的包裹DNA在注射后100天仍可检测到,并且主要分布在注射部位和淋巴器官。静脉内给药会导致更广泛的传播,长期持久性仅限于淋巴器官和网状内皮系统的器官。注射后专业抗原呈递细胞(APC)对DNA的特异性细胞摄取表明微球作为DNA递送剂的效用。分布和持久性研究支持包裹DNA的安全性,而注射后专业APC对DNA的特异性细胞摄取表明微球作为DNA递送剂的效用。